New patent for Salix Pharms drug XIFAXAN

Pharma
Copyright ©
DrugPatentWatch. Originally published at
New patent for Salix Pharms drug XIFAXAN

Annual Drug Patent Expirations for XIFAXAN
Annual Drug Patent Expirations for XIFAXAN

Xifaxan is a drug marketed by Salix Pharms and is included in two NDAs. It is available from three suppliers. There are twenty-seven patents protecting this drug and two Paragraph IV challenges.

XIFAXAN drug price trends.

Drug patent litigation for XIFAXAN.

This drug has one hundred and eigthy-one patent family members in thirty-nine countries.

The generic ingredient in XIFAXAN is rifaximin. Three suppliers are listed for this compound. Additional details are available on the rifaximin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright ©
DrugPatentWatch. Originally published at
New patent for Salix Pharms drug XIFAXAN

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.